Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Aurora Cannabis Inc. (T:ACB)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 500-10355 Jasper Ave NW
Tel: 1-855-2794652
IR: See website
Key People
Michael Singer
Executive Chairman of the Board
Darren Anthony Karasiuk
Chief Commercial Officer
Steve Dobler
President, Director
Terry Booth
Chief Executive Officer, Director
Glen Ibbott
Chief Financial Officer
Allan Cleiren
Chief Operational Officer
Debra Wilson
Chief Human Resource Officer
Rick Savone
Senior Vice President - Global Government Relations
Darryl Andrew Vleeming
Chief Information Officer
Neil Belot
Chief Global Business Development Officer
Business Overview
Aurora Cannabis Inc is a Canada-based medical cannabis company. Through its subsidiaries, the Company manages two operating segments plus Corporate: Medical Cannabis, Horizontally Integrated Businesses and Other. The Medical Cannabis segment produces and distributes medical cannabis in Canada and distributes it via wholesale in the European Union. Additionally, it includes the production and sale of indoor cultivation systems and hemp related food products. The Company's production capacity is of over 625,000 kilograms per year.
Financial Overview
For the six months ended 31 December 2019, Aurora Cannabis Inc revenues increased 57% to C$131.3M. Net loss increased from C$132.3M to C$1.27B. Revenues reflect Cannabis segment increase of 78% to C$140.4M, Canada (Country) segment increase of 75% to C$132.3M, European Union (Region) segment increase of 19% to C$8M. Higher net loss reflects Other Non Operating I/E decrease from C$144.4M (income) to C$0K.
Employees: 3,000 as of Sep 10, 2019
Reporting Currency: Canadian Dollars
Enterprise value: $2,608M as of Dec 31, 2019
Annual revenue (TTM): $295.36M as of Dec 31, 2019
EBITDA (TTM): -$340.24M as of Dec 31, 2019
Net annual income (TTM): -$1,432M as of Dec 31, 2019
Free cash flow (TTM): -$790.22M as of Dec 31, 2019
Net Debt Last Fiscal Year: $419.64M as of Dec 31, 2019
Shares outstanding: 1,168,974,993 as of Jan 28, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization